Clinical Trial

Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study was to further evaluate the long-term safety and efficacy of the Biolimus Coated Coronary Artery Balloon Dilation Catheter in the real world. The study population was patients with primary coronary vascular lesions with a blood vessel diameter of 2.0mm-2.75mm.
Trial Details
NCT Number NCT06385067
Lead Sponsor JW Medical Systems Ltd
Conditions Coronary Artery Disease
Enrollment 400 participants
Start Date 2024-05-10
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-04-25